PT1879655E - Composição farmacêutica compreendendo um agente antibacteriano e uma substância activa seleccionada a partir de carveol, carvacrol, alfa-ionona, beta-ionona, e timol - Google Patents

Composição farmacêutica compreendendo um agente antibacteriano e uma substância activa seleccionada a partir de carveol, carvacrol, alfa-ionona, beta-ionona, e timol Download PDF

Info

Publication number
PT1879655E
PT1879655E PT67447532T PT06744753T PT1879655E PT 1879655 E PT1879655 E PT 1879655E PT 67447532 T PT67447532 T PT 67447532T PT 06744753 T PT06744753 T PT 06744753T PT 1879655 E PT1879655 E PT 1879655E
Authority
PT
Portugal
Prior art keywords
ionone
timol
carveol
carvacrol
beta
Prior art date
Application number
PT67447532T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Advanced Scient Developements
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Scient Developements filed Critical Advanced Scient Developements
Publication of PT1879655E publication Critical patent/PT1879655E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT67447532T 2005-05-13 2006-05-15 Composição farmacêutica compreendendo um agente antibacteriano e uma substância activa seleccionada a partir de carveol, carvacrol, alfa-ionona, beta-ionona, e timol PT1879655E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2005/001313 WO2006120494A1 (fr) 2005-05-13 2005-05-13 Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l’eugenol, le borneol et les carvacrol

Publications (1)

Publication Number Publication Date
PT1879655E true PT1879655E (pt) 2015-02-24

Family

ID=35427275

Family Applications (1)

Application Number Title Priority Date Filing Date
PT67447532T PT1879655E (pt) 2005-05-13 2006-05-15 Composição farmacêutica compreendendo um agente antibacteriano e uma substância activa seleccionada a partir de carveol, carvacrol, alfa-ionona, beta-ionona, e timol

Country Status (13)

Country Link
US (1) US20080214518A1 (https=)
EP (1) EP1879655B1 (https=)
JP (1) JP5410748B2 (https=)
CN (3) CN102319246B (https=)
BR (1) BRPI0610125B8 (https=)
CA (1) CA2606875C (https=)
DK (1) DK1879655T3 (https=)
EA (1) EA014069B1 (https=)
ES (1) ES2530963T3 (https=)
MA (1) MA29606B1 (https=)
PT (1) PT1879655E (https=)
TN (1) TNSN07424A1 (https=)
WO (2) WO2006120494A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2918571B1 (fr) * 2007-07-10 2013-01-11 Aroma Tech Compositions antibiotiques a base d'huiles essentielles prophylaxie et traitement d'infections nosocomiales
EP2214656B1 (en) * 2007-10-26 2018-12-05 Avivagen Inc. Compositions and methods for enhancing immune response
FR2925334A1 (fr) * 2007-12-21 2009-06-26 Ceva Sante Animale Sa Nouvelles compositions antibacteriennes
AU2010242502B2 (en) 2009-04-30 2016-11-10 Avivagen Inc. Methods and compositions for improving the health of animals
AU2010297406B2 (en) 2009-09-24 2013-10-17 Unilever Plc Disinfecting agent comprising eugenol, terpineol and thymol
WO2012076310A1 (en) 2010-12-07 2012-06-14 Unilever Nv An oral care composition
MX2014005405A (es) 2011-11-03 2014-06-23 Unilever Nv Una composicion de limpieza personal.
MX347858B (es) 2011-12-06 2017-05-16 Unilever Nv Composición antimicrobiana.
CN102670619B (zh) * 2012-05-08 2014-02-19 广东药学院 一种头孢氨苄冰片组合物
CN102670598B (zh) * 2012-05-08 2014-07-16 广东药学院 一种青霉素冰片组合物在制备抗菌药物中的应用
CN103146255B (zh) * 2013-02-25 2014-07-09 厦门吉宏包装科技有限公司 一种抑菌驱螨印刷底油母液和由母液制作的印刷底油及其制备方法
CN105357971A (zh) * 2013-05-07 2016-02-24 凯敏工业公司 含有香芹酚和麝香草酚的抗微生物组合物
FR3025719A1 (fr) 2014-09-15 2016-03-18 Septeos Antimicrobiens potentialises
FR3025718A1 (fr) 2014-09-15 2016-03-18 Septeos Antimicrobiens potentialises
WO2016081594A1 (en) * 2014-11-19 2016-05-26 The General Hospital Corporation System and method for photo-dynamic procedure
HK1243951A1 (zh) * 2014-12-18 2018-07-27 Helperby Therapeutics Limited 抗微生物组合和其在治疗微生物感染中的用途
CN107530397A (zh) * 2014-12-18 2018-01-02 赫尔普百治疗有限公司 新型组合和用途
CN109512998A (zh) * 2016-03-04 2019-03-26 广州英赛特生物技术有限公司 含氧碳氢衍生物的酯化衍生物作为多粘菌素的协同增效剂的应用
FR3048612B1 (fr) * 2016-03-14 2020-10-02 Septeos Tulathromycine potentialisee
WO2017209588A2 (fr) 2016-06-02 2017-12-07 Advanced Scientific Developements Formulation pharmaceutique de cinéol et d'amoxicilline
GB201904963D0 (en) * 2019-04-08 2019-05-22 Anpario Plc Composition for reducing antimicrobial resistance
ES2986948T3 (es) 2019-12-04 2024-11-13 Pranarom Int S A Procedimiento de transformación de un aceite esencial
KR102848354B1 (ko) * 2023-02-13 2025-08-21 경상국립대학교산학협력단 테트라사이클린계 항생제와 시너지 효과를 가지는 바닐린 또는 카바크롤을 유효성분으로 포함하는 조성물 및 이의 용도

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4317775A (en) * 1980-01-07 1982-03-02 Hoffmann-La Roche Inc. Amoxicillin derivatives
DE3634697A1 (de) * 1986-10-11 1988-04-21 Dentaire Ivoclar Ets Dentalwerkstoff zur bekaempfung von karies und parodontose
US5213615A (en) * 1986-10-11 1993-05-25 Ivoclar Ag Dental material and method for the control of caries and paradentitis
US5801153A (en) * 1991-09-13 1998-09-01 Badaway; Mohammed A. Method of enhancing the antimicrobial properties of antibacterial antibiotics to massively control and prevent bacterial, fungal, and viral diseases in plants
FR2697133B1 (fr) * 1992-10-28 1995-01-13 Transbiotech Composition biocide et/ou biostatique et ses applications.
US5308873A (en) * 1992-12-18 1994-05-03 Doyle E. Chastain Method of killing yeast and fungi with carveol
US5716928A (en) * 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
CA2224227A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US6319507B1 (en) * 1997-05-02 2001-11-20 Kobo Products, Inc. Agar gel bead composition and method
US6025400A (en) * 1998-08-24 2000-02-15 Marco Polo Technologies Compositions for treatment of antibiotic-resistant gram-positive bacterial infections and methods for using and preparing the same
SE9901733L (sv) * 1999-05-12 2000-11-13 Akzo Nobel Nv En komposition innehållande karvakrol och tymol för användning som bactericid
US6414036B1 (en) * 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
US6495512B1 (en) * 2000-06-23 2002-12-17 International Flavors & Fragrances Inc. Salicylaldehyde-containing composition having antimicrobial and fragrancing properties and process for using same
AU2002211536A1 (en) * 2000-10-06 2002-04-15 Dusan Ninkov Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
US20030064948A1 (en) * 2001-02-08 2003-04-03 Alfred Fahr Invasomes for therapy of disorders, their preparation and use
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
US20030180349A1 (en) * 2001-12-07 2003-09-25 Franklin Lanny U. Respiratory infection prevention and treatment with terpene-containing compositions
US20030225003A1 (en) * 2002-04-18 2003-12-04 Dusan Ninkov Antimicrobial therapeutic compositions for oral and topical use
WO2004045572A1 (en) * 2002-11-21 2004-06-03 J.P.M.E.D. Ltd. Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil
EA200500804A1 (ru) * 2002-12-10 2005-12-29 Биосинексус Инкорпорейтед Топические противоинфекционные композиции
US20040151771A1 (en) * 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
EP2338332B1 (en) * 2004-05-20 2014-02-12 Eden Research Plc Hollow glucan particle or cell wall particle encapsulating a terpene component

Also Published As

Publication number Publication date
CA2606875C (fr) 2015-12-15
MA29606B1 (fr) 2008-07-01
CA2606875A1 (fr) 2006-11-16
CN101175531B (zh) 2011-09-07
CN101175531A (zh) 2008-05-07
EP1879655A2 (fr) 2008-01-23
CN102319246A (zh) 2012-01-18
US20080214518A1 (en) 2008-09-04
BRPI0610125A2 (pt) 2012-09-25
CN103356612B (zh) 2015-04-15
WO2006120494A1 (fr) 2006-11-16
EP1879655B1 (fr) 2014-11-26
CN103356612A (zh) 2013-10-23
CN102319246B (zh) 2013-07-17
DK1879655T3 (en) 2015-02-23
EA014069B1 (ru) 2010-08-30
EA200702483A1 (ru) 2008-04-28
JP2008540507A (ja) 2008-11-20
BRPI0610125B1 (pt) 2020-08-11
JP5410748B2 (ja) 2014-02-05
WO2006120567A3 (fr) 2007-08-23
ES2530963T3 (es) 2015-03-09
WO2006120567A2 (fr) 2006-11-16
TNSN07424A1 (fr) 2009-03-17
BRPI0610125B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
PT1879655E (pt) Composição farmacêutica compreendendo um agente antibacteriano e uma substância activa seleccionada a partir de carveol, carvacrol, alfa-ionona, beta-ionona, e timol
CL2018003398A1 (es) Composición farmacéutica de liberación sostenida que comprende micro-partículas. (divisional de solicitud 2013-03538).
DK3984528T3 (da) Farmaceutiske sammensætninger, som omfatter nilotinib
CL2007003341A1 (es) Compuestos derivados de imidazotriazinas; composicion farmaceutica, util para el tratamiento del cancer, arteroesclerosis y enfermedades cardiovasculares entre otras.
HUE043555T2 (hu) Tetrahidrokannabinol gyógyszer elõanyagai (prodrugjai), kompozíciók, amelyek tetrahidrokannabinol gyógyszer elõanyagait tartalmazzák, és eljárások, ezek alkalmazására
BRPI0811712A2 (pt) "composto, processo de preparação de um composto e composição farmacéutica".
EP1903866A4 (en) IMPROVED RELEASE OF TETRAHYDROCANNABINOL
BRPI0815708A2 (pt) Composto, éster de pró-droga, composição farmacêutica, e, método para tratar uma doença ou condição.
IL228402A0 (en) Nitro-cyclic compounds, their pharmaceutical preparations and their uses
BRPI0820139A2 (pt) Composição antiperspirante ativa, e, processo de obtenção de uma composição antiperspirante ativa
CL2008000691A1 (es) Compuestos derivados de dihidro y tetrahidro oxazolopirimidinonas sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la esquizofrenia, epilepsia, entre otras enfermedades.
BRPI0817423A2 (pt) Processos para a preparação de um composto, para a preparação de uma formulação farmacêutica, e para a preparação de um intermediário de um composto, e, composto
BR122020011920A2 (pt) composto, composição farmacêutica, método para tratar uma doença, uso de um composto, e processos para a preparação de um composto, e para a fabricação de um composto
NL2000690A1 (nl) Gestabiliseerde farmaceutische samenstellingen omvattende fesoterodine.
CL2007001597A1 (es) Compuestos derivados de 2-oxo-piridin-1(2h)-il-tiazol, imidazol o tiofen-carboxamida; composicion farmaceutica; y uso para el tratamiento de una enfermedad mediada por la estearoil-coa-desaturasa, tal como sindrome metabolico, hipertension y diabetes
BRPI0915382A2 (pt) composto, composição farmacêutica, e, método para tratar uma doença ou um distúrbio.
CL2007003356A1 (es) Compuestos derivados de benzopirazoles; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para el tratamiento del asma, inflamacion, entre otras enfermedades.
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
CL2007003272A1 (es) Compuestos derivados de pirazol y triazol sustituidos; y composicion farmaceutica, util para el tratamiento de una enfermedad proliferativa celular.
BRPI1009823A2 (pt) "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."
CL2007001838A1 (es) Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih.
BRPI0903914A2 (pt) Uso de um composto, método para analisar a eficácia de uma composição de liberação prolongada, e, composição farmacêutica.
ATE474561T1 (de) Orodispersible pharmazeutische zusammensetzung für die orale, oromukosale oder sublinguale verabreichung von agomelatin
PT1883452E (pt) Composição farmacêutica contendo um agente antiparasítico e um agente ativo escolhido entre timol, eugenol ou carvacrol
BRPI0919694A2 (pt) composto, composto farmacêutica, uso de um composto, e, método de tratamento de uma doença.